Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

(2023) Stephanie Meier et al.   JAMA Neurology

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

(2022) Pascal Benkert et al.   LANCET NEUROLOGY

Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial

(2022) Thomas Williams et al.   Multiple Sclerosis Journal

CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset

(2020) Francesco Patti et al.   ENVIRONMENTAL RESEARCH

Serum neurofilament light chain

(2020) Orhan Aktas et al.   Neurology-Neuroimmunology & Neuroinflammation

Renal function is associated with blood neurofilament light chain level in older adults

(2020) Shoshin Akamine et al.   Scientific Reports

Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?

(2019) Thaleia Kalatha et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis

(2019) Lorenzo Gaetani et al.   JOURNAL OF NEUROLOGY

Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies

(2019) Sarah-Jane Martin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients

(2019) Diana Ferraro et al.   ACTA NEUROLOGICA SCANDINAVICA

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

(2019) Claire Bridel et al.   JAMA Neurology

Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis

(2019) Lorenzo Gaetani et al.   Multiple Sclerosis and Related Disorders

Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS

(2019) Katja Akgün et al.   Neurology-Neuroimmunology & Neuroinflammation

Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study

(2019) Dejan Jakimovski et al.   Multiple Sclerosis Journal

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

(2018) Nelly Siller et al.   Multiple Sclerosis Journal

Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue

(2018) Bianca Mages et al.   Frontiers in Cellular Neuroscience

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

(2018) Nelly Siller et al.   Multiple Sclerosis Journal

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

(2018) Finn Sellebjerg et al.   Multiple Sclerosis Journal

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Recommendations for cognitive screening and management in multiple sclerosis care

(2018) Rosalind Kalb et al.   Multiple Sclerosis Journal

Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis

(2018) Tanuja Chitnis et al.   Annals of Clinical and Translational Neurology

Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

(2017) Maxim De Schaepdryver et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

(2017) Lauren M Byrne et al.   LANCET NEUROLOGY

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

(2017) Ludwig Kappos et al.   Multiple Sclerosis Journal

Alzheimer disease: Neurofilament light in the blood marks Alzheimer degeneration

(2017) Ian Fyfe   Nature Reviews Neurology

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

(2017) Lenka Novakova et al.   NEUROLOGY

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

(2017) Ludwig Kappos et al.   Multiple Sclerosis Journal

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

(2016) Jens Kuhle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis

(2016) M.Alba Mañé-Martínez et al.   JOURNAL OF NEUROIMMUNOLOGY

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

(2016) Lieke H. Meeter et al.   Annals of Clinical and Translational Neurology

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

(2015) S Modvig et al.   Multiple Sclerosis Journal

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

(2015) J. Kuhle et al.   NEUROLOGY

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

(2015) S Modvig et al.   Multiple Sclerosis Journal

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis

(2014) L. M. Villar et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis

(2014) C Tortorella et al.   Multiple Sclerosis Journal

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers

(2013) Mohsen Khademi et al.   PLoS One

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

(2011) J. Kuhle et al.   NEUROLOGY

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)

(2010) O. Fernández et al.   JOURNAL OF NEUROLOGY

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY